4
Total investments
0
Early stage
1
Mid stage
1
Late stage
2y
Years active
Portfolio
4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Board Observer
May 2026
bitBiome is a synthetic biology company built from their proprietary microbial single-cell microfluidic sequencing technology (bit-MAP). We have spent the last few years building up a large and diverse database (bit-GEM) of over 2 billion microbial sequences (adding additional sequences at a rate of nearly 1 billion per year). bit-GEM draws from many sources including human, animal, and over half coming from environmental samples including soil, seawater and hot springs. bit-GEM therefore offers a unique source of natural enzymes not found in any other private or public sequence library available. Combining bit-GEM with bioinformatics, protein structure analysis tools, and machine learning, we have developed bit-QED, an end-to-end enzyme discovery and development platform.
bitBiome offers a range of services from single cell genomics, database screening and shortlisting, to wet lab evaluation of target sequences and directed evolution campaigns. We are also focused on conducting in-house R&D for applications in chemical, food and nutrition, and life science industries. Discover the full potential of microbes with bitBiome today!
Investor & Board Observer
Mar 2025
Nabaco® is an agricultural science company dedicated to reducing food loss and waste while maximizing produce industry profitability. That’s smart sustainability.
Our flagship product, NatuWrap®, is a food-grade edible coating that protects fresh produce across the supply chain. While similar in concept to other post-harvest products, NatuWrap® is eco-friendly and more cost effective.
Investor & Board Member
Oct 2024
At KROSSLINKER, we innovate and transform Aerogel for challenging insulation applications. Our first product aims to serve the cold-chain biopharma packaging industry by protecting temperature-sensitive pharmaceuticals, precious biologics, and vaccines throughout their shipping journey with our transformative technology.
Experience · 6 entries
All (6)
Investments (4)
Board (4)
2026
Investor & Board Observer
May 2026
bitBiome is a synthetic biology company built from their proprietary microbial single-cell microfluidic sequencing technology (bit-MAP). We have spent the last few years building up a large and diverse database (bit-GEM) of over 2 billion microbial sequences (adding additional sequences at a rate of nearly 1 billion per year). bit-GEM draws from many sources including human, animal, and over half coming from environmental samples including soil, seawater and hot springs. bit-GEM therefore offers a unique source of natural enzymes not found in any other private or public sequence library available. Combining bit-GEM with bioinformatics, protein structure analysis tools, and machine learning, we have developed bit-QED, an end-to-end enzyme discovery and development platform.
bitBiome offers a range of services from single cell genomics, database screening and shortlisting, to wet lab evaluation of target sequences and directed evolution campaigns. We are also focused on conducting in-house R&D for applications in chemical, food and nutrition, and life science industries. Discover the full potential of microbes with bitBiome today!
2025
Investor & Board Observer
Mar 2025
Nabaco® is an agricultural science company dedicated to reducing food loss and waste while maximizing produce industry profitability. That’s smart sustainability.
Our flagship product, NatuWrap®, is a food-grade edible coating that protects fresh produce across the supply chain. While similar in concept to other post-harvest products, NatuWrap® is eco-friendly and more cost effective.
2024
Investor & Board Member
Oct 2024
At KROSSLINKER, we innovate and transform Aerogel for challenging insulation applications. Our first product aims to serve the cold-chain biopharma packaging industry by protecting temperature-sensitive pharmaceuticals, precious biologics, and vaccines throughout their shipping journey with our transformative technology.
Investor & Board Observer
Apr 2024
Craft Health is a Pharmaceutical Drug Delivery company, enabled by 3D Printed Solutions
2023
General Partner
Oct 2023
Valuence Ventures is an early-stage fund backing deeptech innovators in North America and Asia. We invest from pre-Seed to Series A in cleantech and techbio platforms redefining energy, materials, and life sciences that advance planetary and human health.
Show all 6 entries ↓
Investment activity
2024–2026 · 4 investments
Recent (last 2 years)Earlier